| 标题 |
Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medicinal Chemistry 作者:Xiaomei Ren; Xiaofen Pan; Zhang Zhang; Deping Wang; Xiaoyun Lu; et al 出版日期:2013-01-09 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)